U.S. flag

An official website of the United States government

NM_000527.5(LDLR):c.108_109insT (p.Gly37fs) AND Familial hypercholesterolemia

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Oct 19, 2021
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001950850.3

Allele description

NM_000527.5(LDLR):c.108_109insT (p.Gly37fs)

Gene:
LDLR:low density lipoprotein receptor [Gene - OMIM - HGNC]
Variant type:
Insertion
Cytogenetic location:
19p13.2
Genomic location:
Preferred name:
NM_000527.5(LDLR):c.108_109insT (p.Gly37fs)
HGVS:
  • NC_000019.10:g.11100263_11100264insT
  • NG_009060.1:g.15883_15884insT
  • NM_000527.5:c.108_109insTMANE SELECT
  • NM_001195798.2:c.108_109insT
  • NM_001195799.2:c.108_109insT
  • NM_001195800.2:c.108_109insT
  • NM_001195803.2:c.108_109insT
  • NP_000518.1:p.Gly37fs
  • NP_001182727.1:p.Gly37fs
  • NP_001182728.1:p.Gly37fs
  • NP_001182729.1:p.Gly37fs
  • NP_001182732.1:p.Gly37fs
  • LRG_274:g.15883_15884insT
  • NC_000019.9:g.11210939_11210940insT
Protein change:
G37fs
Links:
dbSNP: rs2147210293
NCBI 1000 Genomes Browser:
rs2147210293
Molecular consequence:
  • NM_000527.5:c.108_109insT - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001195798.2:c.108_109insT - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001195799.2:c.108_109insT - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001195800.2:c.108_109insT - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001195803.2:c.108_109insT - frameshift variant - [Sequence Ontology: SO:0001589]

Condition(s)

Name:
Familial hypercholesterolemia
Identifiers:
MONDO: MONDO:0005439; MedGen: C0020445; OMIM: PS143890

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002231506Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Oct 19, 2021)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Molecular spectrum of autosomal dominant hypercholesterolemia in France.

Marduel M, Carrié A, Sassolas A, Devillers M, Carreau V, Di Filippo M, Erlich D, Abifadel M, Marques-Pinheiro A, Munnich A, Junien C; French ADH Research Network., Boileau C, Varret M, Rabès JP.

Hum Mutat. 2010 Nov;31(11):E1811-24. doi: 10.1002/humu.21348.

PubMed [citation]
PMID:
20809525
PMCID:
PMC3152176

Analysis of LDLR variants from homozygous FH patients carrying multiple mutations in the LDLR gene.

Jiang L, Benito-Vicente A, Tang L, Etxebarria A, Cui W, Uribe KB, Pan XD, Ostolaza H, Yang SW, Zhou YJ, Martin C, Wang LY.

Atherosclerosis. 2017 Aug;263:163-170. doi: 10.1016/j.atherosclerosis.2017.06.014. Epub 2017 Jun 8.

PubMed [citation]
PMID:
28645073
See all PubMed Citations (3)

Details of each submission

From Invitae, SCV002231506.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with LDLR-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Gly37Trpfs*15) in the LDLR gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in LDLR are known to be pathogenic (PMID: 20809525, 28645073).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 1, 2024